Cosmo announces Australian regulatory approval of GI GENIUS™
Cosmo Pharmaceuticals N.V. (“Cosmo”) today announced that GI Genius™ has received regulatory approval in Australia.
GI Genius™ is the first system using artificial intelligence to detect olorectal polyps and is already available in Europe.